Seeking Alpha

Forest Laboratories (FRX) to acquire Clinical Data (CLDA) for $30/share in cash and another...

Forest Laboratories (FRX) to acquire Clinical Data (CLDA) for $30/share in cash and another $6/share on milestones. The $1.2B deal is a 6.6% premium to the average share price since CLDA announced FDA approval of its major depressive disorder treatment Viibryd, which sent shares up more than 50%. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)